Omesti Bhd (XKLS:9008) EPS without NRI: RM-0.00 (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Omesti Bhd EPS without NRI?

Omesti Bhd XKLS:9008 +7.69% EPS without NRI is RM-0.00 as of Apr. 2026. The stock has 5 warning signs investors should review. Among 813 Business Services companies, Omesti Bhd ranks worse than 123001.11% on this metric.

Omesti Bhd's earnings per share without non-recurring items for the three months ended in Apr. 2026 was RM0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was RM-0.00.

During the past 12 months, Omesti Bhd's average earnings per share (NRI) Growth Rate was -105.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Omesti Bhd's EPS without NRI or its related term are showing as below:

During the past 13 years, Omesti Bhd's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 32.60% per year. The lowest was -110.50% per year. And the median was -1.55% per year.

XKLS:9008's 3-Year EPS without NRI Growth Rate is not ranked *
in the Business Services industry.
Industry Median: 7.7
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Omesti Bhd's EPS (Diluted) for the three months ended in Apr. 2026 was RM0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was RM-0.00.

Omesti Bhd's EPS (Basic) for the three months ended in Apr. 2026 was RM0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was RM-0.00.


Omesti Bhd  (XKLS:9008) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Omesti Bhd EPS without NRI Related Terms


Omesti Bhd EPS without NRI Historical Data

* Premium members only.

The historical data trend for Omesti Bhd's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omesti Bhd EPS without NRI Chart

Omesti Bhd Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.02 -0.06 -0.11 -0.42

Omesti Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Jan26 Apr26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.00 -0.01 0.00 0.00

XKLS:9008 vs CTAS, CPRT, ULS: EPS without NRI Comparison

For the Specialty Business Services subindustry, Omesti Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omesti Bhd PE Ratio without NRI vs Business Services Industry

For the Business Services industry and Industrials sector, Omesti Bhd's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Omesti Bhd's PE Ratio without NRI falls into.



Omesti Bhd EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of RM-0.00 mean?
Omesti Bhd (XKLS:9008) has a EPS without NRI of RM-0.00 as of Apr. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Omesti Bhd and its competitors. According to the industry distribution chart, Omesti Bhd ranks #999999 out of 813 companies in the Business Services industry.
Is Omesti Bhd's EPS without NRI too high?
Omesti Bhd's current EPS without NRI is RM-0.00. Based on the distribution chart, Omesti Bhd ranks #999999 out of 813 companies in the Business Services industry, which is in the bottom quartile relative to peers.
How does Omesti Bhd's EPS without NRI compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Omesti Bhd ranks #999999 out of 813 companies for EPS without NRI. This places Omesti Bhd in the lower half of its industry. The industry median EPS without NRI is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Business Services company?
The median EPS without NRI among Business Services companies is 7.70, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Omesti Bhd and its competitors. For the Business Services industry, the median EPS without NRI is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omesti Bhd's current EPS without NRI is RM-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omesti Bhd stock overvalued right now?
Based on GuruFocus' analysis, Omesti Bhd (XKLS:9008) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.06, compared to a current price of RM0.07 — trading 16.7% above its estimated fair value. The current EPS without NRI is RM-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Omesti Bhd (XKLS:9008), the current EPS without NRI is RM-0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omesti Bhd Business Description

Address No. 1 Persiaran Jalil 1, Bandar Bukit Jalil, 2-07-01 - Level 7, Plaza Bukit Jalil, Ho Hup Tower - Aurora Place, Kuala Lumpur, SGR, MYS, 57000
Omesti Bhd is focused on the delivery of technology solutions, systems integration services and the provision of recurring maintenance and managed services, predominantly for government and public sector customers. Its segments include Business Performance Services engages in provision of business performance improvement related services; Digital and Infrastructure Services engaged in the provision of a comprehensive range of tele/data communication, networking solutions and related services; and Healthcare Services engaged in the distribution of pharmaceutical products, vaccines and medical devices and provision of various medical services. The majority of the revenue is derived from Business Performance Services segment.